TRDA Entrada Therapeutics, Inc. insider trading

Entrada Therapeutics, Inc. (TRDA) has 56 open-market insider trades by 20 insiders since 2021. Over the last six months insiders net sold $10.3M. The most active filer is Peter S. Kim, Director.

Name	Title	Tier	Trades	Value	Last Trade
Redmile Group, LLC via Jeremy Green	10% Owner	—	1	$20.0M	2021-11-02
Kush Parmar	Dir	—	6	$12.5M	2026-08-10
Andrew J. Schwab	10% Owner	—	2	$6.6M	2025-07-01
MPM BioVentures 2014, L.P. via Luke Evnin	10% Owner	—	4	$3.6M	2026-09-09
MPM Bioventures 2018, L.P. via Oncology Impact Fund (Cayman) Management L.P.	10% Owner	—	4	$3.6M	2026-09-09
5AM Ventures V, L.P. via Kush Parmar	10% Owner	—	3	$3.0M	2026-08-07
Baker Bros. Advisors (GP) LLC via Felix Baker	10% Owner	—	2	$2.9M	2025-11-12
Todd Foley	Dir10% Owner	—	1	$2.0M	2021-11-02
MPM BioVentures 2018 GP LLC	10% Owner	—	1	$1.8M	2024-12-11
BAKER Bros. Advisors L.P. via Julian Baker	10% Owner	—	2	$1.0M	2024-06-25

Insider	Title	Type	Value	Date
MPM BioVentures 2014, L.P.	10% Owner	Sell	$1.9M	2026-09-04
MPM BioVentures 2014, L.P.	10% Owner	Sell	$617K	2026-09-01
MPM Bioventures 2018, L.P.	10% Owner	Sell	$616K	2026-08-27
MPM Bioventures 2018, L.P.	10% Owner	Sell	$462K	2026-08-24
5AM Ventures V, L.P.	10% Owner	Sell	$432K	2026-08-06
Kush Parmar	Director	Sell	$1.1M

TRDA Entrada Therapeutics, Inc. insider trading

Insider Roster (21)

Recent Insider Trades

Related Companies